Download and complete the HUMIRA travel letter from the AbbVie Care web site. Many apps are available to help you keep track of your injections on your mobile device, so you have the information accessible at your fingertips. Download an app from the App Store® or Google PlayTM, or use the calendar app that’s already on your phone.
HUMIRA Complete | Patient Resources & Support
Whether you’re continuing or new to HUMIRA® (adalimumab), find the support & resources you need with HUMIRA Complete. See Important Safety Info & BOXED WARNING.
HUMIRA® (adalimumab) Patient Resources | HUMIRA Complete
HUMIRA Complete has one goal: to provide you with the resources you need—when you need them. Whether it’s injection training or helping you set up medication reminders, HUMIRA Complete makes it easy to get what you need. These patients found the resources they needed with HUMIRA Complete. Already enrolled? What information do you need today?
Adalimumab - Wikipedia
Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.
Humira: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年3月15日 · Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira is used to treat many inflammatory conditions in adults, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira: 7 things you should know - Drugs.com
2023年9月21日 · Humira is a brand (trade) name for adalimumab. Humira (adalimumab) works by binding specifically to TNF-alfa, which is a signaling protein (also called a cytokine) that is released by white blood cells during inflammation that can trigger cell damage or cell death.
Adalimumab (Humira®) Drug Information Sheet : Johns Hopkins
Adalimumab is a drug that reduces the signs and symptoms of moderate to severe rheumatoid arthritis (RA), such as joint swelling, pain, and fatigue. It is also approved for the treatment of psoriatic arthritis and ankylosing spondylitis, juvenile idiopathic arthritis, Crohn’s disease, uveitis, and hidradenitis suppurativa.
HUMIRA® (adalimumab) | For Healthcare Professionals
HUMIRA is indicated for the treatment of rheumatology, dermatology, and gastroenterology indications. Review efficacy, safety data, and more.
HUMIRA® (adalimumab) - FAQs
What is HUMIRA and how does it work? What is the most important information I should know about HUMIRA? Who shouldn't use HUMIRA? Can HUMIRA cure my (or my child’s) disease? What is HUMIRA Citrate-free? How to take or give HUMIRA. When should HUMIRA be used? How often and for how long will HUMIRA be used once prescribed?
HUMIRA is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies...